1 Nurix Therapeutics Inc Receivables Turnover Ratio (NRIX), from the second quarter 2026 to the second quarter 2025 current and historic results, rankings and more - CSIMarket
CSIMarket Company Name, Ticker, Customers, else..
 


• Sales per Employee
• Income per Employee
• Inventory Turnover
• Asset Turnover
• Receivables Turnover
Nurix Therapeutics Inc   (NASDAQ: NRIX)
 

Nurix Therapeutics Inc Accounts Receivables Turnover Ratio from the second quarter 2026 to the second quarter 2025

Quarterly Results, Trends, Rankings, Statistics


According to Nurix Therapeutics Inc Balance Sheet, in the second quarter 2026, company has not reported any Accounts receivable.
See Nurix Therapeutics Inc Balance Sheet

If we take a look into Healthcare sector 497 other companies have achieved higher receivables turnover ratio. While total ranking has deteriorated relative to the period ending May 31 2026 from 49 to 3138.

What is Receivable Turnover Ratio?
What is Nurix Therapeutics Inc Selling?


What is Receivable Turnover Ratio?




Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

NRIX Receivables Turnover Ratio (May 31 2026)
II. Quarter		 (Feb 28 2026)
I. Quarter		 (Nov 30 2025)
IV. Quarter		 (Aug 31 2025)
III. Quarter		 (May 31 2025)
II. Quarter
Y / Y Receivable Change - - - - -
Y / Y Revenue Change -79.47 % -66.12 % 2.21 % -37.29 % 264.34 %
Receivable Turnover Ratio (TTM) - 15.11 17.68 17.62 18.61
NRIX's Total Ranking # 3138 # 49 # 1208 # 54 # 83
Accounts Receivable average collection period days - 24 21 21 20
Seq. Receivable Change - - - - -
Seq. Revenue Change 44.64 % -53.95 % 71.99 % -82.08 % 138.75 %


Receivable Turnover Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry # 170
Healthcare Sector # 498
Overall Market # 3138

Receivable Turnover Ratio Statistics
High Average Low
0.24 0.12 0.05
(Feb 29 2024)   (May 31 2021)





NRIX Company Profile • Back to NRIX Efficiency Comparisons • Compare NRIX Receivables Turnover Ratio to its Competitors

Financial Statements
Nurix Therapeutics Inc 's Accounts Receivable $ 0 Millions Visit NRIX's Balance sheet
Nurix Therapeutics Inc 's Sales TTM $ 37 Millions Visit NRIX's Income Statement
Sources of NRIX's Revenues Visit NRIX's Sales by Geography

Other Accounts Receivable Turnover Ratios
Major Pharmaceutical Preparations Industry Accounts Receivable Turnover Trends and Statistics
Healthcare Sector Accounts Receivable Turnover Statistics
Accounts Receivables Turnover Trends for overall market
NRIX's Receivable Turnover Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and total Market
Highest Ranking Accounts Receivables Turnover
Lowest Ranking Accounts Receivables Turnover

You may also want to know
NRIX's Growth Rates NRIX's Roa NRIX's Inventory Turnover Ratio NRIX's Dividend Comparisons
NRIX's Profitability Ratios NRIX's Roi NRIX's Asset Turnover Ratio NRIX's Dividend Growth
NRIX's Valuation Ratios NRIX's Roe NRIX's Financial Strength Ratios NRIX's Dividend Payout Ratio



Companies with similar Receivables Turnover Ratio for the quarter ending May 31 2026, within Healthcare Sector Receivable Turnover Ratio Revenues for 12 Months ending May 31 2026 Receivable at quarter ending May 31 2026

Date modified: 2026-07-10T05:52:55+00:00



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.